Cocrystal Pharma (STU:8CC) Short-Term Capital Lease Obligation : €0.22 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Cocrystal Pharma Short-Term Capital Lease Obligation?

Cocrystal Pharma's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was €0.22 Mil.

Cocrystal Pharma's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 (€0.11 Mil) to Dec. 2023 (€0.22 Mil) and increased from Dec. 2023 (€0.22 Mil) to Mar. 2024 (€0.22 Mil).

Cocrystal Pharma's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (€0.21 Mil) to Dec. 2022 (€0.23 Mil) but then declined from Dec. 2022 (€0.23 Mil) to Dec. 2023 (€0.22 Mil).

Cocrystal Pharma Short-Term Capital Lease Obligation Historical Data

The historical data trend for Cocrystal Pharma's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cocrystal Pharma Short-Term Capital Lease Obligation Chart

Cocrystal Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.25

0.18

0.21

0.23

0.22

Cocrystal Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.19	0.15	0.11	0.22	0.22

Cocrystal Pharma Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Cocrystal Pharma Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Cocrystal Pharma's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Cocrystal Pharma (STU:8CC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cocrystal Pharma Inc (STU:8CC) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

COCP:USA

Address

19805 North Creek Parkway, Bothell, WA, USA, 98011

Website

https://www.cocrystalpharma.com

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Cocrystal Pharma (STU:8CC) Headlines

No Headlines